Skip to main content
Contact Us
Subscribe
E-Edition
59°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Shattuck Labs, Inc.
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 09, 2024
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
April 01, 2024
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
March 04, 2024
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
February 29, 2024
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces Participation in Upcoming March Conferences
February 26, 2024
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
February 13, 2024
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024
January 08, 2024
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
December 21, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML)
December 13, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation
December 05, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference
November 14, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 09, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023
November 06, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patients at the American Society of Hematology (ASH) 2023
November 02, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 10, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
May 25, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business Highlights
May 09, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces Participation in Upcoming 22nd Annual Needham Virtual Healthcare Conference
April 03, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Presents Preclinical Data at the 2023 American Association for Cancer Research (AACR) Annual Meeting
March 16, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces Participation in Upcoming March Conferences
March 01, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business Updates
February 23, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs to Report Fourth-Quarter and Full-Year 2022 Financial Results on February 23, 2023
February 16, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces Participation in Upcoming SVB Securities Global Biopharma Conference
February 09, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2023
January 09, 2023
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Reports Third Quarter 2022 Financial Results and Recent Business Highlights
November 08, 2022
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Presents Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 07, 2022
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs Announces Participation in Upcoming November Conferences
November 03, 2022
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs to Report Third Quarter 2022 Financial Results on November 8, 2022
November 01, 2022
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Shattuck Labs to Present Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting November 8-12
October 05, 2022
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.